Spots Global Cancer Trial Database for breakthrough cancer pain
Every month we try and update this database with for breakthrough cancer pain cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Quality of Life Study Breakthrough Cancer Pain Treated in Radiation Oncology Services With Palliative Intent | NCT02836379 | Breakthrough Pa... | No intervention | 18 Years - | Angelini Farmacéutica | |
| Quality of Life Study Breakthrough Cancer Pain Treated in Medical Oncology Services (CAVIDIOM) | NCT03435120 | Breakthrough Pa... | No intervention | 18 Years - | Angelini Farmacéutica | |
| A Dose Titration Study of Fentanyl Buccal Soluble Film for Breakthrough Cancer Pain in Taiwan | NCT03669263 | Breakthrough Ca... | Fentanyl buccal... | 20 Years - | Chang Gung Memorial Hospital | |
| Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain | NCT04713189 | Breakthrough Ca... | Inhaled fentany... Placebo | 18 Years - 75 Years | Lee's Pharmaceutical Limited | |
| Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated | NCT02069067 | Advanced Cancer | - | National Cancer Institute, Naples | ||
| Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain | NCT02899884 | Breakthrough Ca... | No Intervention | 18 Years - | Takeda | |
| Observational Registry Study of Quality of Life When Treating BTcP With Abstral | NCT01936636 | Quality of Life Breakthrough Ca... | Fentanyl | 18 Years - | Galena Biopharma, Inc. | |
| A Dose Titration Study of Fentanyl Buccal Soluble Film for Breakthrough Cancer Pain in Taiwan | NCT03669263 | Breakthrough Ca... | Fentanyl buccal... | 20 Years - | Chang Gung Memorial Hospital | |
| Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients | NCT00842829 | Cancer Pain Breakthrough Pa... | Fentanyl Buccal... | 18 Years - | Teva Branded Pharmaceutical Products R&D, Inc. | |
| Quality of Life Study in Patients With Cancer Breakthrough Pain Treated in Palliative Care Units | NCT02840500 | Breakthrough Pa... | No intervention | 18 Years - | Angelini Farmacéutica | |
| Conversion From Fast Acting Oral Opioids to Abstral® | NCT01315886 | Pain | SL fentanyl | 18 Years - | Orexo AB | |
| Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain | NCT03564548 | Cancer Breakthrough Ca... | PPP001 Morphine sulfat... | 18 Years - | Tetra Bio-Pharma | |
| Treatment of Breakthrough Cancer Pain According to European Guidelines | NCT04468490 | Breakthrough Ca... | 18 Years - | Aziende Chimiche Riunite Angelini Francesco S.p.A | ||
| Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain | NCT04713189 | Breakthrough Ca... | Inhaled fentany... Placebo | 18 Years - 75 Years | Lee's Pharmaceutical Limited | |
| Effentora® in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and Tolerability | NCT01400854 | Cancer Pain | Effentora® | 18 Years - | Teva Branded Pharmaceutical Products R&D, Inc. | |
| Fentanyl for Breakthrough Pain in the Emergency Department | NCT01812759 | Pain | Fentanyl Nasal ... Hydromorphone P... Placebo Nasal S... | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
| Treatment of Breakthrough Cancer Pain According to European Guidelines | NCT04468490 | Breakthrough Ca... | 18 Years - | Aziende Chimiche Riunite Angelini Francesco S.p.A | ||
| Observational Registry Study of Quality of Life When Treating BTcP With Abstral | NCT01936636 | Quality of Life Breakthrough Ca... | Fentanyl | 18 Years - | Galena Biopharma, Inc. | |
| Instanyl® Non-Interventional Study | NCT01045603 | Breakthrough Ca... | 18 Years - | Takeda | ||
| Observational Study of Efficacy, Safety and Tolerability of Fentanyl in Korean Cancer Patients | NCT03895762 | Breakthrough Ca... | Abstral Oral Di... | 19 Years - | A.Menarini Asia-Pacific Holdings Pte Ltd | |
| Patient Satisfaction and Quality of Life Impact - PecFent® | NCT01698645 | Breakthrough Ca... | PecFent® (fenta... | 18 Years - | Archimedes Development Ltd | |
| MAnagement of METastatic Disease In Campania (MAMETIC) | NCT04595032 | Metastatic Dise... | 3DCRT, IMRT, VM... | 18 Years - | National Cancer Institute, Naples | |
| Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated | NCT02069067 | Advanced Cancer | - | National Cancer Institute, Naples | ||
| Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients | NCT00842829 | Cancer Pain Breakthrough Pa... | Fentanyl Buccal... | 18 Years - | Teva Branded Pharmaceutical Products R&D, Inc. | |
| Instanyl® Non-Interventional Study | NCT01045603 | Breakthrough Ca... | 18 Years - | Takeda | ||
| A Clinical Trial to Assess the Clinical Benefit of SSR411298 as Adjunctive Treatment for Persistent Cancer Pain | NCT01439919 | Pain Breakthrough Ca... | SSR411298 Placebo (for SS... | 18 Years - | Sanofi | |
| Conversion From Fast Acting Oral Opioids to Abstral® | NCT01315886 | Pain | SL fentanyl | 18 Years - | Orexo AB | |
| Patient Satisfaction and Quality of Life Impact - PecFent® | NCT01693328 | Breakthrough Ca... | PecFent® (fenta... | 18 Years - | Archimedes Development Ltd |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
